High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid

Sorafenib

(2009) Gillian M. Keating et al.   DRUGS

Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

(2009) Bernard Escudier et al.   JOURNAL OF CLINICAL ONCOLOGY

536 THE COMBINATION EVEROLIMUS (RAD001) PLUS SORAFENIB IS SUPERIOR TO SORAFENIB MONOTHERAPY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA

(2009) A.-C. Piguet et al.   JOURNAL OF HEPATOLOGY

Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice

(2009) B. Blanchet et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Liquid chromatography–tandem mass spectrometric assay for sorafenib and sorafenib–glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite

(2008) Rolf W. Sparidans et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development of a rapid and sensitive LC–MS/MS assay for the determination of sorafenib in human plasma

(2007) Lokesh Jain et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS